University of Pennsylvania | Pathology and Laboratory Medicine

Penn's Gene Therapy Startup Raises Another $50 Million

January 09, 2019

Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.

UPHS Laboratory Test Formulary Committee Established

January 08, 2019

Dr. Irving Nachamkin, Director of Laboratory Medicine, appointed as Inaugural Chair.

National Blood Foundation Early-Career Grant for Dr. Vijay Bhoj

January 07, 2019

Award for research in the fields of transfusion medicine and cellular therapies.

New Faculty Members in the Department for the Academic Year 2018-19

January 01, 2019

Nineteen faculty members join the Department in the Anatomic Pathology, Laboratory Medicine, Experimental Pathology Divisions and at CHOP.

American Society of Cytopathology Volunteer Award for Dr. Roseann Wu

November 18, 2018

Award recognizes her role in recruiting new members.

Visit to Department Facilities by UK Parliamentary Under Secretary of State for Health Lord James O'Shaughnessy

October 05, 2018

Clinical Cell and Vaccine Production Facilities (CVPF) part of tour about cancer-fighting innovations and the Penn Cancer immunorevolution.

A Behind-the-Scenes Look at Pathology and Laboratory Medicine

September 27, 2018

Every day, between 12,000 and 15,000 specimens (blood samples and other fluids, tissues, etc.) make their way to the pathology labs at Penn Medicine, where more than 6,000 different types of tests are performed.

Drs. Lauren Schwartz and Zubair Baloch Part of The Pathologist's Power List 2018

September 21, 2018

Both are cited as among the 100 of the best, brightest, and most powerful advocates of pathology and laboratory medicine.

Stem Cell Lab Part of New Treatment for Lung Complications

September 21, 2018

Nationwide trial using adult stem cells to battle Acute Respiratory Distress Syndrome.

New Analysis in the British Medical Journal Challenges Current Estimates of Dormant Tuberculosis Worldwide

September 20, 2018

New York Times article highlights a BMJ study co-authored by Dr. Paul Edelstein that questions current thinking about latent tuberculosis given the testing methodology for the bacterium.